Accessibility Menu
 
Shattuck Labs logo

Shattuck Labs

(NASDAQ) STTK

Current Price$6.44
Market Cap$459.44M
Since IPO (2020)-67%
5 Year-78%
1 Year+553%
1 Month+52%

Shattuck Labs Financials at a Glance

Market Cap

$459.44M

Revenue (TTM)

$1.00M

Net Income (TTM)

$48.81M

EPS (TTM)

$-0.77

P/E Ratio

-8.30

Dividend

$0.00

Beta (Volatility)

1.42 (Average)

Price

$6.44

Volume

443,022.993

Open

$6.07

Previous Close

$6.42

Daily Range

$6.06 - $6.50

52-Week Range

$0.69 - $6.81

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Shattuck Labs

Industry

Biotechnology

Employees

40

CEO

Taylor H. Schreiber, MD, PhD

Headquarters

Austin, TX 78703, US

STTK Financials

Key Financial Metrics (TTM)

Gross Margin

-2%

Operating Margin

-51%

Net Income Margin

-49%

Return on Equity

-60%

Return on Capital

-61%

Return on Assets

-54%

Earnings Yield

-12.05%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$459.44M

Shares Outstanding

71.56M

Volume

443.02K

Short Interest

0.00%

Avg. Volume

676.54K

Financials (TTM)

Gross Profit

$2.69M

Operating Income

$51.51M

EBITDA

$47.84M

Operating Cash Flow

$39.88M

Capital Expenditure

$71.00K

Free Cash Flow

$39.95M

Cash & ST Invst.

$78.06M

Total Debt

$1.58M

Shattuck Labs Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$906.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$459.44M

N/A

Market Cap/Employee

$10.44M

N/A

Employees

44

N/A

Net Income

$12.59M

+32.6%

EBITDA

$12.38M

+33.8%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$76.48M

+9.9%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$1.58M

-36.8%

Short Term Debt

$0.00

-100.0%

Return on Assets

-53.62%

N/A

Return on Invested Capital

-61.24%

N/A

Free Cash Flow

$8.49M

+51.1%

Operating Cash Flow

$8.49M

+51.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
OVIDOvid Therapeutics Inc.
$2.20+1.85%
CNTXContext Therapeutics Inc.
$2.72+2.64%
STROSutro Biopharma, Inc.
$23.78-4.38%
ZNTLZentalis Pharmaceuticals, Inc.
$2.63+2.33%

Trending Stocks

Symbol / CompanyPricePrice Chg
SKYQSky Quarry
$5.10+1.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.37-0.11%
INTCIntel
$50.38+0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.33+0.00%

Questions About STTK

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.